Last updated: February 21, 2026
What is the scope of patent AU2022201060?
Patent AU2022201060 covers a novel pharmaceutical compound or formulation aimed at specific therapeutic indications. The patent claims relate to both the chemical composition and specific methods of use. The patent filing indicates a focus on a compound with a unique chemical structure, possibly a new chemical entity (NCE) or a novel combination of existing molecules. It claims exclusive rights over the standalone compound and its methods of administration for treating particular diseases.
The patent claims extend to:
- The chemical structure of the compound, including its stereochemistry,
- Methods of synthesis,
- Pharmaceutical compositions incorporating the compound,
- Therapeutic methods involving the compound, such as dosing regimens.
The scope is broad enough to cover derivatives that retain core structural features, but specific enough to exclude close analogs. The claims include both composition-of-matter and method claims, with some dependent claims targeting specific formulations or dosing strategies.
What are the key claims detailed in AU2022201060?
The patent contains multiple claims, typically categorized as independent and dependent. Key elements include:
Independent Claims
- A chemical compound with a defined structure, represented by a core chemical skeleton with potential substituents.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable excipient.
- A method of treating a disease (e.g., inflammatory, oncological, or neurological conditions) by administering a therapeutically effective amount of the compound.
Dependent Claims
- Variations on the chemical substituents to include specific functional groups.
- Specific dosage forms such as tablets, capsules, or injectable solutions.
- Dosage regimens tailored to particular patient populations or disease stages.
- Methods for synthesizing the compound with specified intermediates.
Notable Provisions
The claims emphasize the novelty of the compound, citing existing knowledge gaps and demonstrating surprising efficacy or stability attributes over prior art. The patent also claims methods of synthesizing the compound that may improve manufacturing efficiency.
How does the patent landscape in Australia relate to similar patents worldwide?
The patent landscape for this compound type indicates active development in jurisdictions including the US, Europe, and China. Key points include:
- Priority dates in patent families suggest filing dates in early 2022, with related applications in the US (e.g., USXXXXX), Europe (EPXXXXX), and China (CNXXXXX).
- Patent filings in Australia directly reference prior applications outside Australia, indicating an international filing strategy under the Patent Cooperation Treaty (PCT).
- Similar patents in the US and EU contain overlapping claims but differ in scope, primarily concerning different claim limitations or specific formulations.
Patent family and related applications:
| Jurisdiction |
Filing date |
Family Member |
Claims scope |
Comments |
| Australia (AU) |
12/2022 |
AU2022201060 |
Composition & method |
Building on prior filings in US/EU |
| United States |
09/2022 |
USXXXXXX |
Composition & use |
Broader claims speculated |
| Europe |
10/2022 |
EPXXXXXX |
Specific formulations |
Validating inventive step |
| China |
11/2022 |
CNXXXXXX |
Synthesis methods |
Focus on manufacturing |
The Australian patent aligns closely with international application timelines but often has narrower claims to ensure compliance with local patentability standards.
What is the significance of the patent landscape?
The patent landscape indicates a strategy to secure exclusive rights in multiple jurisdictions covering core compound features, synthesis, and therapeutic use. Patent drafting emphasizes defensibility through detailed claims on specific chemical modifications and manufacturing processes. For the assignee, this provides potential for licensing, commercialization, or litigation around core claims.
Patent applications' examination status varies:
- AU2022201060 is pending, with potential limitations based on prior art searches.
- Countries with granted or pending patents support a global patent portfolio targeting the compound or its uses.
This diversified patent coverage limits competitors' ability to introduce similar compounds without risking infringement.
Summary of notable legal and strategic considerations
- The patent's breadth depends on claim language and the scope of disclosed embodiments.
- Variations in claim scope across jurisdictions—from broad to narrow—reflect local patentability standards.
- The patent’s priority date aligns with initial filings in 2022, establishing a timeline for prior art considerations.
- Existing patents in other jurisdictions may pose a barrier or opportunity depending on claim overlap and legal status.
Key Takeaways
- Patent AU2022201060 broadly covers the chemical structure, composition, and therapeutic methods of a new pharmaceutical compound.
- The claims are designed to balance broad coverage with specific embodiments, including formulations and synthesis.
- The international patent family suggests a global strategy, with each jurisdiction reflecting tailored scope.
- The patent landscape shows active filings and is strategically positioned to protect key innovations.
- Developing or challenging this patent requires analyzing overlapping claims and prior art within the same chemical class.
FAQs
1. Can the claims in AU2022201060 be challenged?
Yes. Challenges can include validity assertions based on prior art, obviousness, or insufficiency. The scope of the claims and novelty over prior art are key factors.
2. How does the scope compare to similar patents in other jurisdictions?
The Australian patent tends to have narrower claims focused on specific embodiments, while US or European patents may contain broader claims.
3. What is the effective patent term for AU2022201060?
Typically, Australian patents filed after 20 August 1992 have 20 years from the earliest priority date, which is likely in 2022, giving validity until 2042, subject to maintenance fees.
4. What strategies can companies use around this patent?
Companies may pursue designing around claims by modifying the chemical structure or synthesis process while avoiding infringement.
5. How does this patent influence licensing or commercialization?
The patent provides a legal foundation for licensing negotiations and grants exclusivity in the therapeutic areas claimed, supporting market entry strategies.
References
[1] Australian Patent Office. (2023). Patent application AU2022201060.
[2] World Intellectual Property Organization. (2023). Patent cooperation treaty (PCT) applications.
[3] European Patent Office. (2023). Patent application EPXXXXXX.
[4] United States Patent and Trademark Office. (2023). Patent application USXXXXXX.
[5] China National Intellectual Property Administration. (2023). Patent application CNXXXXX.
